Vemtoberant is a beta3-adrenergic receptor inhibitor with a human Ki of 8.2 nM, and exhibits 400- to 600-fold selectivity over human beta1-AR and beta2-AR. Vemtoberant attenuates beta3-AR-mediated cardiac inhibition. Vemtoberant can be used for the research of systolic heart failure[1].
Molecular Weight:
619.75
Purity:
99.08
CAS Number:
[2169905-68-2]
Formula:
C29H37N3O8S2
Target:
Adrenergic Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted